TotalMarketCap

Vyome

HINDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$11.300 M

$1.61 -6.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Vyome (HIND) has a market capitalization of $11.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$319.7K

#3529 by revenue

Earnings

-$10.3M

Loss-making

Shares outstanding

7,018,528

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #406Tvardi TherapeuticsTVRD$11.5M
  2. #407AEON BiopharmaAEON$11.3M
  3. #408VyomeHIND$11.3M
  4. #409Cellectar BiosciencesCLRB$11.0M
  5. #410Lisata TherapeuticsLSTA$10.8M

What if Vyome were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,023,190

Per share 2,498,876× higher

Bitcoin $1.53T

$217,687.82

Per share 135,210× higher

Apple $5.02T

$714,648.81

Per share 443,881× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Vyome are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.